Correlation Between Neuropace and Intelligent Bio
Can any of the company-specific risk be diversified away by investing in both Neuropace and Intelligent Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Intelligent Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Intelligent Bio Solutions, you can compare the effects of market volatilities on Neuropace and Intelligent Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Intelligent Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Intelligent Bio.
Diversification Opportunities for Neuropace and Intelligent Bio
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Neuropace and Intelligent is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Intelligent Bio Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intelligent Bio Solutions and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Intelligent Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intelligent Bio Solutions has no effect on the direction of Neuropace i.e., Neuropace and Intelligent Bio go up and down completely randomly.
Pair Corralation between Neuropace and Intelligent Bio
Given the investment horizon of 90 days Neuropace is expected to generate 0.32 times more return on investment than Intelligent Bio. However, Neuropace is 3.13 times less risky than Intelligent Bio. It trades about 0.09 of its potential returns per unit of risk. Intelligent Bio Solutions is currently generating about 0.01 per unit of risk. If you would invest 158.00 in Neuropace on August 24, 2024 and sell it today you would earn a total of 742.00 from holding Neuropace or generate 469.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neuropace vs. Intelligent Bio Solutions
Performance |
| Timeline |
| Neuropace |
| Intelligent Bio Solutions |
Neuropace and Intelligent Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neuropace and Intelligent Bio
The main advantage of trading using opposite Neuropace and Intelligent Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Intelligent Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intelligent Bio will offset losses from the drop in Intelligent Bio's long position.| Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
| Intelligent Bio vs. Acme United | Intelligent Bio vs. 51Talk Online Education | Intelligent Bio vs. United Guardian | Intelligent Bio vs. Eastern Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |